Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-23T13:45:56.512Z Has data issue: false hasContentIssue false

Out of Bounds: Physician Licensing Board Disciplinary Cases related to Opioid Prescribing

Published online by Cambridge University Press:  16 December 2024

Carol L. Galletly
Affiliation:
MEDICAL COLLEGE OF WISCONSIN, MILWAUKEE, WISCONSIN, USA
Erika A. Christenson
Affiliation:
BOSTON MEDICAL CENTER, BOSTON, MASSACHUSETTS, USA
Jessica Ohlrich
Affiliation:
MEDICAL COLLEGE OF WISCONSIN, MILWAUKEE, WISCONSIN, USA
Julia Dickson-Gomez
Affiliation:
MEDICAL COLLEGE OF WISCONSIN, MILWAUKEE, WISCONSIN, USA
Rights & Permissions [Opens in a new window]

Abstract

Physician prescribing practices contributed to the US opioid epidemic, leading to increased regulation of opioid prescribing. In some instances, prescribers are unscrupulous or corrupt. They are criminally investigated and subject to prosecution. Less egregious opioid prescribing infractions are addressed through state medical licensing boards. At stake are physicians’ licenses to practice medicine.

Type
Independent Articles
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of American Society of Law, Medicine & Ethics

The first wave of the current US overdose epidemic involved increased prescription opioid mortality in the 1990s, followed by a second wave of increases in deaths involving heroin around 2010.Reference Campbell1 The current third wave is characterized by illicitly manufactured fentanyl driving overdose mortality rates to record highs. Almost half (47%) of persons who inject drugs (PWID) are estimated to have one or more nonfatal lifetime overdosesReference Mark2, and 50–58% of PWID report witnessing a prior year fatal or non-fatal overdose of a peer.Reference Morgan3 The current opioid crisis started as a result of an increase in the number of opioid prescriptions caused by overmarketing.Reference Lindsey4

Several mechanisms have been put in place to prevent misprescribing of opioid based medication. These include electronic prescription drug monitoring programs (PDMPs), limits on the quantity of opioids that may be prescribed, compulsory face-to-face examination, medication contracts, drug screening, and pill counts for patients on long-term treatment.5 Unlike many other areas of medicine, detailed guidelines on opioid prescribing have been incorporated in state statutes.Reference Reidenberg6 Federal regulations are also used to control opioid prescribing and prevent patient misuse.Reference Gatchel7 Whether these are effective in stemming the epidemic and whether they put physicians at risk for unintended legal consequences is not clear.

Medical Practice Standards

Much of the attention to physicians’ misprescribing of opioids has been focused on “Pill Mills,” or instances when physicians abuse their prescribing privileges and engage in illegal drug distribution.Reference Dineen and DuBois8 These activities are motivated by physician self-interest — legitimate treatment of patients is absent. These are addressed primarily through the criminal law.9

Along with the criminal law, the practice of medicine is regulated by each state’s Medical Practice Act (MPA).Reference Davis and Carr10 MPAs outline standards for medical treatment, physician professionalism, and professional ethics and require that a physician’s treatment of patients falls within commonly accepted standards of care. Physicians may not provide care that falls below the treatment provided by a “careful, competent” physician or that “departs from or fails to conform to acceptable and prevailing standards.”11 These standards of care apply to patient diagnosis, subsequent treatment, follow-up, documentation, and when applicable, final outcomes.12 Given variations in patient history and diagnoses and multiple potential courses of treatment, this standard must be applied on a case-by-case basis and may require the specialized knowledge of persons familiar with prevailing medical practices.Reference Yeon13 Criminal behavior related to the practice of medicine is a de facto violation of a state’s MPA and often precedes final medical licensing board (MLB) actions.

Physician Discipline

Allegations of physician practices falling outside of the accepted standard of care are adjudicated by MLBs. Created by each state’s MPA, MLBs provide a mechanism for review of cases by physician peers who are familiar with prevailing medical standards. Some MLBs also include community representatives.14

Evidence suggests that concerns about potential entanglement in legal processes related to alleged opioid misprescribing make some physicians reluctant to prescribe opioids. This can result in the under-treatment of pain and/or reluctance to treat patients with pain or opioid use disorders.

State MLBs can apply a variety of sanctions, or orders, in physician disciplinary cases. At their least severe, official board orders range from issuing a public letter of reprimand to requiring a physician to complete continuing education courses. At their most severe, MLB orders may limit, suspend, or even revoke a physician’s privilege to prescribe controlled substances, and at the most extreme, may preclude them from practicing medicine entirely.

Although incompetent medical providers should never provide care, the consequences of a Board’s determination that a physician acted outside of treatment standards can be devastating for the provider.Reference Landess15. Besides jeopardizing his or her professional standing, disciplined physicians may lose hospital practice privileges, fail to meet requirements for further employment, be deemed high risk for malpractice insurance, and/or be barred from billing patients under public insurance. In all US states, physicians who engage in anything deemed to be the practice of medicine after their medical license is revoked commit a crime.Reference Rowthorn16 Indeed, the Federation of State Medical Boards (FSMB), the professional organization representing MLBs, recommends that practicing medicine without a license be a felony offense.17 Even when an MLB concludes that a physician’s practices were within standards of care, being investigated for a license infraction can be costly, time consuming, and unnerving.18

Cases on the Margins and Physicians’ Concerns

Evidence suggests that concerns about potential entanglement in legal processes related to alleged opioid misprescribing make some physicians reluctant to prescribe opioids.Reference Goldenbaum19 This can result in the under-treatment of pain and/or reluctance to treat patients with pain or opioid use disorders.Reference Buchan and Tolle20 For the average, law-abiding physician, this apprehension is not likely to stem from concerns about being “caught” for engaging in intentional, criminal wrongdoing such as operating an illegal drug distribution enterprise; instead physicians may be concerned about inadvertently violating, or being perceived as having violated, opioid-related laws and MPAs.Reference Hoffmann and Tarzian21 Of particular concern may be the possibility that a physician could be sanctioned for a prescribing irregularity because of a patient’s, not the physician’s, misuse of controlled substances. In the traditional American Medical Association’s “4-D” classification of physician misprescribing, that physicians are “dishonest,” “dated,” “disabled,” or “duped,”Reference Wesson and Smith22 these physicians are “duped” — they fail to identify drug-seeking patients. Their oversight does not rise to the level of criminal intention or “willful blindness,” but it falls below minimum, accepted practice standards. Yet physicians are notoriously poor at detecting patient malingering or deception, and efforts to do so could undermine trust within the physician-patient relationship.Reference Jung and Reidenberg23

As an alternative to the “4-D” framework, Dineen & DuBois in 2016 offered a framework organized around “3 C’s”; physicians are “corrupt,” “compromised,” or “careless.” The “duped” category is replaced by carelessness or failure to maintain minimum accepted practice standards.24 The authors emphasize that cases should only be assigned to the “careless” category when a physician’s actions or failure to act are repeated or amount to a pattern of behavior rather than a single oversight or error.

Although studies suggest that physician discipline cases related to opioid prescribing are rare,Reference Richard and Reidenberg25 as are physician discipline cases in general,Reference Harris and Byhoff26 misprescribing controlled substances is one of the leading causes of physician disciplinary actions.Reference Arora27 Fear about inadvertently running afoul of opioid prescribing laws and regulations appears to affect practice.

Previous Analyses of Disciplinary Cases

A number of studies have examined MLB physician disciplinary actions and criminal prosecutions related to misprescribing controlled substances including opioids.Reference Davis and Carr28 Most examine criminal cases or cases where resulting MLB orders are the most severe, such as license suspension, license revocation, or surrender in lieu of revocation.29 Fewer studies have examined the relatively less severe infractions that may concern physicians because their deviations from standards of care are inadvertent or based on unique case characteristics rather than willful behavior involving extreme, more easily detected prescribing.Reference Richard and Reidenberg30 Even fewer studies report on data collected within the previous decade. With the implementation of PDMPs in all but one state in the US, thus increasing opportunities for review of physicians’ prescribing practices, up-to-date analyses of cases are critical.

As part of a multi-state study of the influence of laws and policies related to the prescribing of controlled substances on the drug use behavior of persons who use illicit drugs, we examined opioid-related physician disciplinary cases in three US states.

Methods

We examined formal physician disciplinary proceedings in three diverse US states — Connecticut, Kentucky, and Wisconsin. Disciplinary proceedings involving both Medical Doctors and Doctor of Osteopathic Medicine were included. Records were collected for the five-year period from January 1, 2014–December 31, 2018 from board order reports published on each state’s website. These reports indicate the MLBs’ findings of fact, conclusions of law (i.e., the specific violation of the state MPA), and the MLB orders or sanctions.

Case Inclusion Criteria

Cases were included if there was an MLB case report available for an event or events related to opioids, the opioid-related event took place in Connecticut, Kentucky, or Wisconsin, and the event occurred between January 1, 2014–December 31, 2018. Cases based on an opioid-related event or events that took place prior to 2014 were excluded, although an MLB inquiry, hearing, order, or follow-up order may have extended into the study timeframe. Where multiple records addressed a single or closely related event, these were treated as a single case. When a physician was involved in two or more unrelated events within the study timeframe, these were treated as separate cases, although sanctions for the second case were often influenced by the first case. All other cases were excluded.

Because final MLB board orders are a matter of public record, the study was not subject to Institutional Review Board approval. The larger study of which this was a part was, however, reviewed by Institutional Review Board at the fourth author’s institution and was determined to meet legal and ethical standards for research involving human subjects.

Data Analysis

Relevant features of cases were entered into an Excel database. These included characteristics of providers, case characteristics, source of complaint, and resulting MLB orders or sanctions. The data were analyzed through a combination of iterative, open coding processes,31 and the application of codes developed in previous studies of physician disciplinary cases. (See e.g., FSMB, 2018b32, Clay, 2003Reference Clay and Conatser33, Goldbaum, 2008.34) Although at times the case report might suggest something that was not directly stated (e.g., that an individual was running a “pill mill” or a particular patient was diverting opioids) we were careful not to apply our own interpretation of events and reported instead only that which was explicitly stated in the case report.

Case Descriptors

Physician Characteristics

Gender, type of medical degree (i.e., MD or DO), and primary type of medicine practiced were recorded for each case. For analysis, practice areas were combined into nine categories: family or internal medicine; emergency medicine; psychiatry; pain management; obstetrics/gynecology; occupational medicine/physical medicine and rehabilitation; pediatrics; surgery; neurology; and other ( Table 1 ).

Table 1 Licensee Characteristics

Percentages in columns are percentages of characteristics within the state’s total cases.

Percentages may not equal 100% due to rounding.

Case Characteristics

For analysis, physician’s actions underlying board conclusions were divided into ten categories: failure to diagnose appropriately; failure to treat appropriately; failure to educate patient/procure informed consent; failure to manage opioid patients appropriately; failure to maintain records; prescribing outside of physician-patient relationship; self-use; failure to heed indicators of patient abuse or patient drug diversion (when explicitly stated in report); inappropriate delegation of prescribing privilege; and opioid-related criminal allegations ( Table 2 ). Because disciplinary actions most often involve several deviations from practice standards, each was included in case characteristic counts separately.

Table 2 Physician violations

Percentages within states are percentages of characteristics within the state’s total cases.

Percentages may not equal 100% due to rounding.

Source of Complaint

When the information was provided, we noted how licensees came to the attention of the MLB. These were also divided into ten categories ranging from routine prescribing reviews (some prompted by previous cases involving the physician), information from law enforcement including coroners, and complaints by other medical providers or the patient or family members themselves. When cases came to the attention of the MLB from more than one source, we selected the earliest source. When no information on how the case was detected was provided, this was indicated ( Table 3 ).

Table 3 Cases Involving Suboxone/Subutex and/or Methadone and Patient Mortality

Percentages within states are percentages of characteristics within the state’s total cases.

Percentages may not equal 100% due to rounding.

MLB Orders

MLB Orders were also grouped into ten categories: license revocation or surrender/voluntary retirement; license suspension; license restriction; continuing medical education; professional assessment and remediation; physician supervision; substance use disorder treatment and abstinence; monetary fine; and reprimand ( Table 4 ). MLB disciplinary orders are most often applied to cases in combination. Consistent with our coding of case characteristics, each was coded as a discrete order.

Table 4 Source of Complaints Prompting Physician Disciplinary Action9

Percentages in columns are percentages of characteristics within the state’s total cases.

Percentages may not equal 100% due to rounding.

Table 5 Disciplinary Orders

Percentages in columns are percentages of characteristics within the state’s total cases.

Percentages may not equal 100% due to rounding.

Table Endnotes

1. Pathology

2. Cardiology; radiology; urology

3. Three anesthesiologists

4. Criminal allegations are indicated by criminal investigation/charges with probable cause. These cases include both criminal acts related to opioid diversion and to self-use.

5. One licensee was convicted of a crime in another state

6. Didn’t clearly discharge patient/dismissed/abandoned patient; Failed to document APRN supervision plan; Prescribed opioids without Controlled Substance Registration; Prescribed injectable medications to office staff for administration to patients; Physician impaired by illness; Wrote prescriptions for a colleague whose Controlled Substance Registration was revoked; Wrote a prescription in one name for another person; Failed to maintain control of prescription pad; Stored patients’ medications; Didn’t clearly discharge patient/dismissed or abandoned patient; Physician “stocking up” on medications before Controlled Substance Registration lapsed.

7. Failure to supervise staff; Prescription pad displayed the address of an office that was closed; Practicing beyond training; Gave small amount of licensee’s own medication and marijuana to friend; Stole/misappropriated medication; Alleged exchange of treatment for a car discount; Sexual misconduct/inappropriate relationship with patient; Failure to supervise staff; Sexual misconduct/inappropriate relationship with patient; Prescribed for self with colleague’s Controlled Substance Registration unbeknownst to colleague; Physically impaired; Stole/misappropriated medication for self-use; Staff member who was terminated for altering a prescription for self-use was rehired; Noncompliance with previous order resulting in license suspension and subsequent practice without a license; Unnecessary surgery for personal financial gain.

8. Treatment outside of the office; Prescribed controlled substances without a medical license; HIPAA violation; Improper drug disposal; Prescribed to persons known to have opioid use disorders; Abuse of authority to avoid concerns about physician’s prescribing; Practicing beyond training; Abuse of authority when concerns were expressed about physician’s prescribing practices; Treatment outside of office; Treatment outside of office; Illegal billing; Sexual misconduct/inappropriate relationship with patient; Didn’t clearly discharge patient; Board found not in violation.

9. The source of complaints was not reported in Connecticut case records.

10. Complaint prompted during supervision from a previous order; Complaint prompted by an investigation related to patient’s other prescriber; Complaint prompted by a medical emergency at the licensee’s home

11. Complaint by group home staff

12. Records for five licensees indicated that their restrictions were permanent.

13. Records for two licensees indicated that their restrictions were permanent.

In cases where a physician was deemed to be a potential risk to the public, immediate, ex parte emergency suspensions were ordered until the case went through investigation and adjudication processes. We noted when this occurred but did not include these as separate cases unless this was the only Board action taken. In some instances, Board actions against a physician would be taken because he or she failed to comply with previous orders. These were not included in case counts.

Case Categories

We developed three mutually exclusive categories to describe disciplinary cases — those that involved misprescribing — actions that didn’t extend over a long time period, didn’t involve large numbers of patients, and weren’t indicative of a pattern of misfeasance; those that involved overprescribing — more serious infractions, often criminal, that involved larger amounts of opioids prescribed to large numbers of patients and/or over an extended time with evidence of a pattern of malfeasance; and those that involved self-use.

Results

Overview

We identified 140 opioid-related actions across the three study states over our 5-year study period. Connecticut recorded 27 actions (19%), Kentucky recorded 75 (54%), and Wisconsin recorded 38 (27%). Historically, more physician disciplinary actions of any kind are reported in Kentucky than in Connecticut and Wisconsin.Reference Harris and Byhoff35 This appears to be consistent for opioid-related cases as well.

Nature of the Case Reports

The level of detail provided in case reports varied widely between states. Connecticut’s case reports were brief and provided minimal detail about the circumstances surrounding the allegations or the process to case resolution. Detailed facts of cases, sources of complaints, and investigative procedures were not typically described. Physicians’ subsequent meetings with the MLB to be returned to full practice privileges and compliance or noncompliance with orders were also rarely presented. Wisconsin’s case reports, on the other hand, were more detailed. Patient visits were described and physicians’ actions and concerns as noted in patient charts (or information missing in charts) were outlined. Information on case context was typically provided allowing the complaint source and circumstances leading to the complaint to be identified. Interim hearings before the MLB and compliance with orders were also provided as these developed. Kentucky’s case reports provided the most detail. Outside consultants performed chart reviews based on consistent criteria. Consultants’ impressions of the physician’s activities were often provided, as were, on some occasions, the chart evaluations themselves. Kentucky also provided investigative details such as information from interviews conducted and, in some cases, the physician’s response to the charges and perspective on the circumstances prompting them. Like Wisconsin, Kentucky case reports provided sufficient details to identify how the physician came to the attention of the MLB and subsequent compliance with orders and interim MLB hearings with the physician.

Characteristics of Physicians Disciplined

Table 1 describes the characteristics of physicians involved in formal disciplinary MLB hearings. The majority of physicians disciplined in opioid-related cases were male (87%, 122) and practiced allopathic medicine (94%, 132). Well over half of the physicians practiced general, family, or internal medicine (61%, 85). For comparison, in 2012, 64.4% of physicians in the US were male, 91% practiced allopathic medicine, and most of those with specialties were certified in family, general, and/or internal medicine.36 Within our sample, the next most represented specialties were pain management with 10 cases (7%) and psychiatry with 9 cases (6%). Notably, none of the physicians disciplined in Connecticut specialized in pain management. This may be due to differences in descriptions of medical specializations.

Nature of the Cases

The facts of cases ranged widely though were limited by the information provided in reports. Cases of self-use ranged from physicians diverting opioids for their own use with no noted deleterious consequences to physicians who were impaired while practicing — notably, one physician was visibly impaired while working in the operating room. Other cases involved theft of medication and physicians writing prescriptions for themselves in others’ names. Several cases of self-use involved associated law enforcement involvement.

Cases characterized as misprescribing often involved physicians prescribing opioids without establishing or maintaining a formal physician-patient relationship. These cases involved prescribing to friends and family, improperly delegating prescribing privileges to office staff, and prescribing outside of a formal office setting. In most, but not all, of these cases, the prescriptions appeared to be for legitimate medical purposes and otherwise followed prescribing guidelines.

Other cases of misprescribing involved failures to properly diagnose and manage established patients taking opioids, often long-term, or failure to heed indicators of abuse. These included failures to conduct drug screens or failure to act quickly on irregular results, prescribing large amounts of opioids and/or in combinations favored for abuse, filling prescriptions early and/or disregarding instances involving multiple providers. A number of these cases were based on the physician’s failure to refer patients receiving opioids to appropriate specialists.

In the most egregious cases, identified here as over-prescribing, physicians prescribed very high doses of medications to large numbers of patients with cursory or no examination and follow-up and no clear treatment purposes. These cases often involved concomitant insurance fraud or other criminal activity. Though the term is rarely used, the facts of cases, when presented, suggest that the physician was knowingly involved in a criminal enterprise or a “pill mill.”

Case Characteristics

The number of disciplinary actions brought to the board did not vary greatly among the years examined. As indicated in Table 2 , the most commonly cited violation was failure to maintain records (80; 57%) However, there were no cases where failure to maintain records was the sole cause for disciplinary action. In many cases, inadequate recordkeeping served as a proxy for actions not taken by physicians when indicated.

Other common grounds for disciplinary action included failure to treat appropriately, often prescribing increasingly large amounts of opioids to a single patient or not considering patient symptoms or progress (77; 55%) and failure to manage opioid patients appropriately (63; 45%), often involving lack of routine drug screening or lack of consideration about patients’ histories of drug misuse. Well over one-third of cases (29; 43%) involved a physician prescribing outside of the physician-patient relationship. A total of 26 (19%) cases involved the prescribing of suboxone/subutex, methadone, or both. Over 10% of cases (15; 11%) involved patient death and 27 cases (19%) involved criminal investigation, charges, and/or prosecution.

How the Cases Came to the Attention of the Medical Licensing Boards

Information on how cases came to the attention of the MLBs was consistently reported in Kentucky’s case reports. This information was reported for many but not all cases in Wisconsin and was rarely reported in Connecticut. As Table 3 indicates, in Wisconsin and Kentucky, 24 cases were identified by a pharmacist or other healthcare provider (17%). An additional 21 cases (19%) were detected by the coroner and other law enforcement officers and 11% (12) of cases were detected by routine monitoring, though Wisconsin did not report identifying cases in this way. A total of 12 cases (16%) in Kentucky and no cases in Wisconsin explicitly referenced the state’s PDMP as a prompting event for complaint. Still, PDMPs were often referenced as a tool during case investigations to identify the patients of a physician under investigation for whom chart review was appropriate.

Board Orders or Penalties

In the majority of cases physicians were required to complete continuing education courses (102; 73%) and in many cases, physicians were required to complete professional assessment and remediation plans (33; 23%) and/or be supervised in their practice (32; 23%). A total of 25 physicians (18%) were reprimanded. These are typically public reprimands and recorded in the physician’s record. At times, reprimand was the only action taken by the board; however, reprimands were also combined with other penalties including fines. In Connecticut, fines ranged from $3,000 to $20,000 (mean $5900). In Kentucky, fines ranged from $1,000 to $5,000 (mean $2,600), and the single fine recorded in Wisconsin was $3,000. In some cases, physicians were required to pay federal and civil fines as well.

Across the three study states, 25 (18%) of all disciplinary actions reported resulted in the Board taking the most severe licensing action, either license revocation or surrender. These cases included physicians voluntarily retiring. Further, in 19 (17%) cases, MLBs ordered ex parte emergency suspensions or restrictions. In these cases, the physicians were deemed to be an imminent danger to patients and thus action was taken prior to a formal hearing. The Kentucky MLB did not report ordering any emergency suspensions, though these may have been ordered and recorded elsewhere.

Physicians were also required to reimburse their MLB for the costs to investigate and adjudicate their cases. These costs ranged widely, from $100-$250 in simple cases to more than $10,000 in those that were very complex or contentious.

Between State Comparisons

Although reliable comparisons between states are limited due to the small number of cases reported and the limited information provided about some cases, three statistically significant between-state differences emerged among violations reported. First, compared to the Connecticut and Wisconsin MLB, the Kentucky MLB rarely cited failure to educate patients about opioids as a violation (8.29 (p=.016)) There were also marginally significant differences in Wisconsin’s use of failure to diagnose properly (5.77 (p=.056)). Wisconsin cited this much less frequently than Connecticut and Kentucky. On the other hand, Wisconsin cited failure to heed indicators of abuse at double the percentage of Connecticut and Kentucky. 5.85 (p=.054)

Discussion

Cases rarely involved a single incident, suggesting that MLBs adhere to the suggestion by Dineen et al. that physician discipline is only appropriate when infractions are repeated or ongoing.37 This may be reassuring to physicians who fear repercussions because of their treatment of a single case or worse, a single decision they have made.38 Many cases were based on actions that physicians did not take rather than their prescribing decisions. These included cases where a formal physician-patient relationship was not established, diagnosis was cursory, case notes were absent or inadequate, and importantly, the physician failed to monitor patients receiving longer-term opioid treatment. Some of these infractions are inconsistent with state law or MLB prescribing recommendations, suggesting that enhanced regulations, while reflecting best practices, may prompt increased disciplinary actions. It is important to note, however, that the physicians in these cases often overlooked serious signs of drug diversion and addiction or prescribed amounts of opioids or combinations of medications that could jeopardize patients.

A significant portion of cases involved methadone and suboxone. Although patients being treated for opioid use disorders may be among the most challenging, enhanced regulations related to prescribing these drugs also play a role in physician’s infractions. For example, several physicians exceeded the allowed number of patients receiving suboxone and at least one violated regulations regarding storage and dispensing. Today, the cap on numbers of patients a physician can see for methadone and suboxone treatment has been lifted.

MLB orders relied heavily on continuing medical education courses (CMEs). The effectiveness of these on modifying physician behavior does not appear to have been examined. Still, it is questionable that 15–20 hours of continuing education will substantially alter a physician’s practices in these serious cases. In Kentucky, required CMEs are often coupled with physician evaluation and individualized practice plans. This may be a more effective approach.

Although physicians are not often required to pay fines, one element of disciplinary actions that is often overlooked is that disciplined physicians are often required to reimburse the costs of adjudication, which can be substantial. Many cases also require physicians to be supervised for as long as one year, often at the physician’s expense. Further, cases may extend for more than two years, and physicians may be required to go before the MLB several times before their license is reinstated in full. The cost of adjudication and supervision and the time and effort taken to regain full practice privileges may increase physicians’ concerns about being brought before their MLBs and in some cases may motivate more careful diagnosis, treatment, and record keeping.

Conclusions

It is critical that physicians keep careful records, consistently conduct routine screenings, and ensure that a documented physician-patient relationship is established for each patient receiving opioids. A closer examination of MLB cases related to medications used to treat substance use disorders is also indicated. Law and policy makers should ensure that distrust of medications to treat opioid use disorder is not manifested in regulations. More consistent physician disciplinary case reporting across US states is needed to identify and to address trends in cases.

Acknowledgements

This study was funded by National Institute on Drug Abuse R01 DA044971. The authors have no conflicts of interest to report.

References

Campbell, B.K., et al, “Facilitating Outpatient Treatment Entry Following Detoxification for Injection Drug Use: A Multisite Test of Three Interventions,” Psychology of Addictive Behaviors, 23, no. 2 (2009): 260270; T.L. Mark et al., “Factors Associated with the Receipt of Treatment Following Detoxification,” Journal of Substance Abuse Treatment, 24, no. 4 (2003): 299–304, doi: https://doi.org/10.1016/s0740-5472(03)00039-4; B.D. Stein et al., “Substance Abuse Detoxification and Residential Treatment Among Medicaid Enrolled Adults: Rates and Duration Of Subsequent Treatment,” Drug & Alcohol Dependence, 104, no. 1-2 (2009): 100–106, doi: https://doi.org/10.1016/j.drugalcdep.2009.04.008.CrossRefGoogle ScholarPubMed
Mark, T.L. et al., “Factors Affecting Detoxification Readmission: Analysis of Public Sector Data from Three States,” Journal of Substance Abuse Treatment, 31, no. 4 (2006): 439445, doi: https://doi.org/10.1016/j.jsat.2006.05.019.CrossRefGoogle ScholarPubMed
Morgan, J.R. et al., “Opioid Overdose and Inpatient Care for Substance Use Disorder Care in Massachusetts,” Journal of Substance Abuse Treatment, 112 (2020): 4248, doi: https://doi.org/10.1016/j.jsat.2020.01.017.CrossRefGoogle ScholarPubMed
Lindsey, E.D. et al., “A Recent History of Opioid Use in the US: Three Decades of Change,” Substance Use & Misuse 54, no. 2 (2018): 331339, doi: https://doi.org/10.1080/10826084.2018.1517175.Google Scholar
Opioid Regulations: State by State Guide, The American College of Emergency Physicians, available at <https://www.acep.org/siteassets/sites/acep/media/by-medical-focus/opioids/opioid-guide-state-by-state.pdf> (last visited September 9, 2024); Harm Reduction Legal Project, 50 State Survey, Laws Limiting the Prescribing or Dispensing of Opioids, The Network for Public Health Law, available at <https://www.networkforphl.org/wp-content/uploads/2021/05/50-State-Survey-Laws-Limiting-the-Prescribing-or-Dispensing-of-Opioidspf-CSD_FINAL.pdf> (last visited September 9, 2024)+(last+visited+September+9,+2024);+Harm+Reduction+Legal+Project,+50+State+Survey,+Laws+Limiting+the+Prescribing+or+Dispensing+of+Opioids,+The+Network+for+Public+Health+Law,+available+at++(last+visited+September+9,+2024)>Google Scholar
Reidenberg, M.M. et al., “Prosecution of Physicians for Prescribing Opioids to Patients,” Clinical Pharmacology & Therapeutics 81, no. 6 (2007): 903906.CrossRefGoogle ScholarPubMed
Gatchel, R.J., “Is Fear of Prescription Drug Abuse Resulting in Sufferers of Chronic Pain Being Undertreated?Expert Review of Neurotherapeutics 10, no. 5 (2010): 637639.CrossRefGoogle ScholarPubMed
Dineen, K.K. and DuBois, J.M.. “Between a Rock and a Hard Place: Can Physicians Prescribe Opioids to Treat Pain Adequately While Avoiding Legal Sanction? American Journal of Law & Medicine 42, no. 1 (2016): 752.CrossRefGoogle Scholar
See Dineen, id; See Reidenberg, supra note 7.Google Scholar
Davis, C.S. and Carr, D.H.. “Self-Regulating Profession? Administrative Discipline of “Pill Mill” Physicians In Florida,” Substance Abuse 38, no. 3 (2017): 265268.CrossRefGoogle ScholarPubMed
Federation of State Medical Boards of the United States (FSMB), US Medical Regulatory Trends and Actions 2018, available at <https://www.fsmb.org/siteassets/advocacy/publications/us-medical-regulatory-trends-actions.pdf> (last visited September 9, 2024).+(last+visited+September+9,+2024).>Google Scholar
Yeon, H.B. et al., “Physician Discipline,” JBJS 88, no. 9 (2006): 20912096.Google ScholarPubMed
FSMB(b), 2018 Guidelines for Function and Structure of a State Medical or Osteopathic Board, adopted April 2018, available at <https://www.fsmb.org/siteassets/advocacy/policies/guidelines-for-the-structure-and-function-of-a-state-medical-and-osteopathic-board.pdf> (Last visited September 9, 2024).+(Last+visited+September+9,+2024).>Google Scholar
See Dineen, supra note 9; Landess, J., “State Medical Boards, Licensure, and Discipline in the United States,” Focus 17, no. 4 (2019): 337342; L. Barre et al., “Review of Rhode Island Physician Loss-of-Licensure Cases, 2009–2019,” Rhode Island Medical Journal 103, no. 4 (2020): 46–49.CrossRefGoogle ScholarPubMed
Rowthorn, V et al., “Not Above the Law: A Legal and Ethical Analysis of Short-Term Experiences in Global Health,” Annals of Global Health 85, no 1 (2019): 79, doi: https://doi.org/10.5334/aogh.2451.CrossRefGoogle Scholar
See FSMB(b), supra note 15.Google Scholar
See Dineen, supra note 9.Google Scholar
See Dineen, supra note 9; See Reidenberg, supra note 7; Goldenbaum, D.M. et al., “Physicians Charged with Opioid Analgesic-Prescribing Offenses,” Pain Medicine 9, no. 6 (2008): 737747; M. Barnes et al., “Opioid Prescribing and Physician Autonomy: A Quality of Care Perspective,” HSS Journal 15, no. 1 (2019): 20–26.CrossRefGoogle ScholarPubMed
See Reidenberg, supra note 7; Buchan, M.L. and Tolle, S.W., “Pain Relief for Dying Persons: Dealing with Physicians’ Fears and Concerns,” The Journal of Clinical Ethics 6, no. 1 (1995): 5361.CrossRefGoogle ScholarPubMed
See Dineen, supra note 9; Hoffmann, D.E. and Tarzian, A.J.. “Achieving the Right Balance in Oversight of Physician Opioid Prescribing for Pain: The Role of State Medical Boards,” Journal of Law, Medicine & Ethics 31, no. 1 (2003): 2140; See Barnes, supra note 20.CrossRefGoogle ScholarPubMed
Wesson, D.R. and Smith, D.E., “Prescription Drug Abuse: Patient, Physician, and Cultural Responsibilities,” Western Journal of Medicine 152, no. 5 (1990): 613.Google ScholarPubMed
Jung, B. and Reidenberg, M.M., “The Risk of Action by the Drug Enforcement Administration Against Physicians Prescribing Opioids for Pain,” Pain Medicine 7, no. 4 (2006): 353357.CrossRefGoogle ScholarPubMed
See Dineen, supra note 9.Google Scholar
Richard, J., and Reidenberg, M. M., “The Risk of Disciplinary Action by State Medical Boards Against Physicians Prescribing Opioids,” Journal of Medical Regulation 91, no. 2 (2005): 1419; See Goldenbaum, supra note 20.CrossRefGoogle Scholar
See FSMB, supra note 12; Harris, J.A. and Byhoff, E., “Variations by State in Physician Disciplinary Actions by US Medical Licensure Boards,” BMJ Quality & Safety 26, no. 3 (2017): 200208.CrossRefGoogle Scholar
See Barre, supra note 16; Arora, K.S. et al., “What Brings Physicians to Disciplinary Review? A Further Subcategorization,” AJOB Empirical Bioethics 5, no. 4 (2014): 5360; Landess, supra note 16.CrossRefGoogle Scholar
See Reidenberg, supra note 7; See Jung, supra note 24; See Goldenbaum, supra note 20; Davis, C.S. and Carr, D.H., “Self-Regulating Profession? Administrative Discipline of “Pill Mill” Physicians in Florida,” Substance Abuse 38, no. 3 (2017): 265268; J.M. DuBois et al., “A Mixed-Method Analysis of Reports on 100 Cases of Improper Prescribing of Controlled Substances,” Journal of Drug Issues 46, no. 4 (2016): 457–472.CrossRefGoogle ScholarPubMed
See Id.; See Goldenbaum, supra note 20; See Reidenberg, supra note 7.Google Scholar
See DuBois, supra note 29; Richard, J. and Reidenberg, M.M., “The Risk of Disciplinary Action by State Medical Boards Against Physicians Prescribing Opioids,” Journal of Medical Regulation 91, no. 2 (2005): 1419.CrossRefGoogle Scholar
See Arora, supra note 28.Google Scholar
See FSMB, supra note 12.Google Scholar
Clay, S.W. and Conatser, R.R., “Characteristics of Physicians Disciplined by the State Medical Board of Ohio.” Journal of Osteopathic Medicine 103, no. 2 (2003): 8188.Google ScholarPubMed
See Goldenbaum, supra note 20.Google Scholar
Harris, J.A. and Byhoff, E., “Variations by State in Physician Disciplinary Actions by US Medical Licensure Boards,” BMJ Quality & Safety 26, no. 3 (2017): 200208; See FSMB, supra note 12.CrossRefGoogle Scholar
See FSMB, supra note 12.Google Scholar
See Dineen, supra note 9.Google Scholar
See Lindsay, supra note 5; See Dineen, supra note 9; See Buchan supra note 21; See Reidenberg, supra note 7.Google Scholar
Figure 0

Table 1 Licensee Characteristics

Figure 1

Table 2 Physician violations

Figure 2

Table 3 Cases Involving Suboxone/Subutex and/or Methadone and Patient Mortality

Figure 3

Table 4 Source of Complaints Prompting Physician Disciplinary Action9

Figure 4

Table 5 Disciplinary Orders